Arelang Naturals Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 29-07-2024
- Paid Up Capital ₹ 5.67 M
as on 29-07-2024
- Company Age 4 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 4.00 M
as on 29-07-2024
- Revenue 170.37%
(FY 2023)
- Profit -78.66%
(FY 2023)
- Ebitda -73.27%
(FY 2023)
- Net Worth -663.37%
(FY 2023)
- Total Assets -6.48%
(FY 2023)
About Arelang Naturals
The Company is engaged in the E-Commerce Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 5.67 M.
The company currently has active open charges totaling ₹4.00 M.
Prnav Munim, Aamir Shaikh, Nikita Naterwalla, and One other member serve as directors at the Company.
- CIN/LLPIN
U74999MH2020PTC349115
- Company No.
349115
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Oct 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Arelang Naturals?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nikita Naterwalla  | Director | 01-Apr-2021 | Current |
| Prnav Munim | Director | 30-Oct-2020 | Current |
| Aamir Shaikh | Director | 01-Jun-2021 | Current |
| Cyrus Naterwalla | Director | 30-Oct-2020 | Current |
Financial Performance of Arelang Naturals.
Arelang Naturals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 170.37% increase. The company also saw a substantial fall in profitability, with a 78.66% decrease in profit. The company's net worth observed a substantial decline by a decrease of 663.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Arelang Naturals?
In 2023, Arelang Naturals had a public holding of 80.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
₹0.40 Cr
₹0
Charges Breakdown by Lending Institutions
- Yes Bank Limited : 0.40 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 03 Mar 2023 | Yes Bank Limited | ₹4.00 M | Open |
How Many Employees Work at Arelang Naturals?
Arelang Naturals has a workforce of 0 employees as of Jul 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arelang Naturals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arelang Naturals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.